Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,431
archived clinical trials in
Back Pain

Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Torrance Clinical Research
mi
from
Lomita, CA
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Torrance Clinical Research
mi
from
Lomita, CA
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Probe Clinical Research Corporation - Santa Ana
mi
from
Santa Ana, CA
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Probe Clinical Research Corporation - Santa Ana
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Lake Internal Medicine Associates
mi
from
Eustis, FL
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Lake Internal Medicine Associates
mi
from
Eustis, FL
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Eastern Research, Inc.
mi
from
Hialeah, FL
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Eastern Research, Inc.
mi
from
Hialeah, FL
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Palm Springs Research Institute
mi
from
Hialeah, FL
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Palm Springs Research Institute
mi
from
Hialeah, FL
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Health Awareness
mi
from
Jupiter, FL
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Health Awareness
mi
from
Jupiter, FL
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Compass Research LLC
mi
from
Orlando, FL
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Martin E. Hale, MD PA (Gold Coast Research LLC)
mi
from
Plantation, FL
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Martin E. Hale, MD PA (Gold Coast Research LLC)
mi
from
Plantation, FL
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Accord Clinical Research
mi
from
Port Orange, FL
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Accord Clinical Research
mi
from
Port Orange, FL
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
International Clinical Research
mi
from
Sanford, FL
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
International Clinical Research
mi
from
Sanford, FL
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
MediSphere Medical Research Center, LLC
mi
from
Knight, IN
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
MediSphere Medical Research Center, LLC
mi
from
Knight, IN
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Beacon Clinical Research, LLC
mi
from
Brockton, MA
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Beacon Clinical Research, LLC
mi
from
Brockton, MA
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Independent Clinical Researchers
mi
from
Las Vegas, NV
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Independent Clinical Researchers
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Clinical Study Center of Asheville, LLC
mi
from
Asheville, NC
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Clinical Study Center of Asheville, LLC
mi
from
Asheville, NC
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Wake Research Associates, LLC
mi
from
Raleigh, NC
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
The Center for Clinical Research
mi
from
Winston-Salem, NC
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
The Center for Clinical Research
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Hightop Physicians Inc./Medical Research Center
mi
from
Cincinnati, OH
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Hightop Physicians Inc./Medical Research Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Community Research
mi
from
Cincinnati, OH
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Community Research
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Community Research - Anderson
mi
from
Cincinnati, OH
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Community Research - Anderson
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
New Horizons Clinical Research
mi
from
Cincinnati, OH
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
New Horizons Clinical Research
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Health Research Institute
mi
from
Oklahoma City, OK
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Health Research Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
DeGarmo Institute of Medical Research
mi
from
Greer, SC
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
DeGarmo Institute of Medical Research
mi
from
Greer, SC
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Pain Specialists of Charleston
mi
from
North Charleston, SC
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Pain Specialists of Charleston
mi
from
North Charleston, SC
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Health Concepts
mi
from
Rapid City, SD
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Health Concepts
mi
from
Rapid City, SD
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
FutureSearch Trials of Neurology, LP
mi
from
Austin, TX
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
FutureSearch Trials of Neurology, LP
mi
from
Austin, TX
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Clinical Trial Network
mi
from
Houston, TX
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Clinical Trial Network
mi
from
Houston, TX
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
ClinRx Research LLC
mi
from
Plano, TX
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
ClinRx Research LLC
mi
from
Plano, TX
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Sun Research Institute
mi
from
San Antonio, TX
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Sun Research Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated:  12/6/2012
Charlottesville Medical Research Center, LLC
mi
from
Charlottesville, VA
Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)
An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain
Status: Enrolling
Updated: 12/6/2012
Charlottesville Medical Research Center, LLC
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Meditation for Low Back Pain
Meditation for Low Back Pain
Status: Enrolling
Updated:  1/28/2013
University of Wisconsin-Madison
mi
from
Madison, WI
Meditation for Low Back Pain
Meditation for Low Back Pain
Status: Enrolling
Updated: 1/28/2013
University of Wisconsin-Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Limit Computed Tomography (CT) Scanning in Suspected Renal Colic
Validation of a Decision Rule to Limit CT Scanning in Suspected Renal Colic
Status: Enrolling
Updated:  2/14/2013
Shoreline Medical Center
mi
from
Guilford, CT
Limit Computed Tomography (CT) Scanning in Suspected Renal Colic
Validation of a Decision Rule to Limit CT Scanning in Suspected Renal Colic
Status: Enrolling
Updated: 2/14/2013
Shoreline Medical Center
mi
from
Guilford, CT
Click here to add this to my saved trials
Limit Computed Tomography (CT) Scanning in Suspected Renal Colic
Validation of a Decision Rule to Limit CT Scanning in Suspected Renal Colic
Status: Enrolling
Updated:  2/14/2013
Yale University, Emergency Department
mi
from
New Haven, CT
Limit Computed Tomography (CT) Scanning in Suspected Renal Colic
Validation of a Decision Rule to Limit CT Scanning in Suspected Renal Colic
Status: Enrolling
Updated: 2/14/2013
Yale University, Emergency Department
mi
from
New Haven, CT
Click here to add this to my saved trials
Guaifenesin - Muscle Relaxant - Upper Back Pain
A Proof of Principle Study to Explore the Utility of Guaifenesin in Upper Back Pain
Status: Enrolling
Updated:  3/7/2013
Med Investigations
mi
from
Sacramento, CA
Guaifenesin - Muscle Relaxant - Upper Back Pain
A Proof of Principle Study to Explore the Utility of Guaifenesin in Upper Back Pain
Status: Enrolling
Updated: 3/7/2013
Med Investigations
mi
from
Sacramento, CA
Click here to add this to my saved trials
Guaifenesin - Muscle Relaxant - Upper Back Pain
A Proof of Principle Study to Explore the Utility of Guaifenesin in Upper Back Pain
Status: Enrolling
Updated:  3/7/2013
San Diego Sports Medicine and Family Health Center
mi
from
San Diego, CA
Guaifenesin - Muscle Relaxant - Upper Back Pain
A Proof of Principle Study to Explore the Utility of Guaifenesin in Upper Back Pain
Status: Enrolling
Updated: 3/7/2013
San Diego Sports Medicine and Family Health Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Guaifenesin - Muscle Relaxant - Upper Back Pain
A Proof of Principle Study to Explore the Utility of Guaifenesin in Upper Back Pain
Status: Enrolling
Updated:  3/7/2013
Radiant Clinical Research - Cincinnati
mi
from
Sycamore, OH
Guaifenesin - Muscle Relaxant - Upper Back Pain
A Proof of Principle Study to Explore the Utility of Guaifenesin in Upper Back Pain
Status: Enrolling
Updated: 3/7/2013
Radiant Clinical Research - Cincinnati
mi
from
Sycamore, OH
Click here to add this to my saved trials
Guaifenesin - Muscle Relaxant - Upper Back Pain
A Proof of Principle Study to Explore the Utility of Guaifenesin in Upper Back Pain
Status: Enrolling
Updated:  3/7/2013
Radiant Research, Inc. - TX
mi
from
San Antonio, TX
Guaifenesin - Muscle Relaxant - Upper Back Pain
A Proof of Principle Study to Explore the Utility of Guaifenesin in Upper Back Pain
Status: Enrolling
Updated: 3/7/2013
Radiant Research, Inc. - TX
mi
from
San Antonio, TX
Click here to add this to my saved trials
Guaifenesin - Muscle Relaxant - Upper Back Pain
A Proof of Principle Study to Explore the Utility of Guaifenesin in Upper Back Pain
Status: Enrolling
Updated:  3/7/2013
J. Lewis Research, Inc.
mi
from
Salt Lake City, UT
Guaifenesin - Muscle Relaxant - Upper Back Pain
A Proof of Principle Study to Explore the Utility of Guaifenesin in Upper Back Pain
Status: Enrolling
Updated: 3/7/2013
J. Lewis Research, Inc.
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Alabaster, AL
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Alabaster, AL
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Gilbert, AZ
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Gilbert, AZ
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Los Angeles, CA
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Arvada, CO
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Arvada, CO
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Atlantis, FL
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Atlantis, FL
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Atlanta, GA
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Avon, IN
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Avon, IN
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Baltimore, MD
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Boston, MA
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Cape Girardeau, MO
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated:  6/27/2013
Pfizer Investigational Site
mi
from
Alliance, NE
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
A Multicenter, 12-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Determine the Efficacy and Safety Of ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) Extended-Release Capsules in Subjects With Moderate to Severe Chronic Low Back Pain
Status: Enrolling
Updated: 6/27/2013
Pfizer Investigational Site
mi
from
Alliance, NE
Click here to add this to my saved trials